Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07295795 · ClinicalTrials.gov registry record
Blood Sampling Pre- and Post-Propofol Administration to Characterize the Blood Proteome Using Different Research Assays
A clinical trial of Critically Ill Surgical Patients, sponsored by National Institutes of Health Clinical Center (CC).
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT07295795 is a study of Critically Ill Surgical Patients that is actively recruiting participants, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07295795, a study of Critically Ill Surgical Patients, is actively recruiting participants, sponsored by National Institutes of Health Clinical Center (CC).
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Propofol is a drug that helps people fall asleep quickly and stay asleep during surgery, so they do not feel any pain. This drug is also used to sedate critically ill people who must be on a ventilator (a machine to help them breathe). To better understand how to interpret blood tests in these ill people, researchers need to know more about how the drug itself may change proteins in the blood. Objective: To collect blood samples from people before and after propofol is administered for surgery. Eligibility: People aged 18 years or older who are scheduled for surgery that requires sedation with propofol. Design: Participants will have data collected. This data will include age, sex, and ethnicity. They will be asked about their medical history. Participants will have blood samples collected before and after they receive propofol for their surgery. The blood will be collected from lines already installed for the surgery; no new needlesticks will be done for the study. A total of 3 teaspoons of blood will be drawn. The samples will be compared to each other to look for any changes caused by the drug. No follow-up visits are required.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-02-10 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07295795
The ClinicalTrials.gov registry entry for NCT07295795 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Critically Ill Surgical Patients appearing as the primary indexed condition, and to 0 interventions.
NCT07295795 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT07295795 about?
NCT07295795 is a clinical study titled "Blood Sampling Pre- and Post-Propofol Administration to Characterize the Blood Proteome Using Different Research Assays". Background: Propofol is a drug that helps people fall asleep quickly and stay asleep during surgery, so they do not feel any pain. This drug is also used to sedate critically ill people who must be on a ventilator (a machine to help them breathe). To better understand how to interpret blood tests i...
What is the current status of trial NCT07295795?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2026-02-10. Estimated completion is 2026-12-31.
What conditions does trial NCT07295795 study?
This clinical trial studies the following conditions: Critically Ill Surgical Patients.
Who is sponsoring clinical trial NCT07295795?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07295795 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.